This has been questioned [16] as the prevalence of deficiency in such cohorts is clearly higher than expected in the UK indigenous general population [17] and indeed may influence current and future management as systemic AAT augmentation abrogates the airways inflammatory process in AATD [14] and hence excessive putative local airway damage. Here, SERPINA1 is linked to alpha 1-antitrypsin deficiency.